Bonds Lian, Baker Paige, Gup Carol, Shroyer Kenneth R
Department of Pathology, School of Medicine, University of Colorado Health Sciences Center, Denver 80262, USA.
Arch Pathol Lab Med. 2002 Oct;126(10):1164-8. doi: 10.5858/2002-126-1164-ILOCIS.
Cdc6 has been extensively studied as a marker for cellular proliferation that is expressed during the normal cell cycle. Recent studies indicate that Cdc6 may be a marker for cervical intraepithelial neoplasia (CIN) and carcinoma; however, the histologic distribution of Cdc6 has not been explicitly defined. Expression of Cdc6 in the endocervical mucosa also remains unexplored.
The goal of the current study was to evaluate the distribution of Cdc6 protein, MIB-1 protein, and human papillomavirus (HPV) DNA in a broad range of cervical tissues, including normal, potentially premalignant, and malignant lesions of the ectocervical and endocervical mucosa.
We used an indirect immunoperoxidase method to stain formalin-fixed, paraffin-embedded tissues and frozen tissues, including biopsy and hysterectomy specimens, for Cdc6 and MIB-1 proteins, and we used in situ hybridization to detect HPV DNA in a subset of cases.
Cdc6 staining was exclusively nuclear and was present in both squamous and glandular epithelial cells of histologic sections. Cdc6 staining was rarely present in specimens of normal cervical squamous mucosa (2/84, 2.4%) or in specimens with squamous metaplasia (3/59, 5.1%) and was not detected in normal endocervical glands (0/84). Staining was present in most cases of CIN I (31/48, 65%). Staining was present in the majority of cases of CIN II (25/28, 89%) and in all cases of CIN III (36/36) and squamous cell carcinomas (34/34). The proportion of cells staining for Cdc6 increased with the grade of dysplasia, and the proportion of stained cells in squamous cell carcinomas was similar to that in lesions of high-grade dysplasia. Cdc6 staining was present in the majority of cases in glandular lesions including adenocarcinoma in situ (11/14, 79%) and adenocarcinoma (8/10, 80%). The histologic distribution of Cdc6-immunoreactive cells was similar to that of cells with a strong signal for HPV DNA, but Cdc6 protein and HPV DNA did not colocalize at the level of individual cells.
Cdc6 expression is a marker for high-grade cervical squamous and glandular dysplasia and carcinoma and is associated with HPV infection. The mechanistic basis of the association between HPV infection and Cdc6 immunopositivity remains to be determined but may represent either up-regulation of Cdc6 expression or stabilization of the Cdc6 protein.
细胞分裂周期蛋白6(Cdc6)作为一种在正常细胞周期中表达的细胞增殖标志物,已得到广泛研究。最近的研究表明,Cdc6可能是宫颈上皮内瘤变(CIN)和癌的标志物;然而,Cdc6的组织学分布尚未明确界定。宫颈内膜黏膜中Cdc6的表达情况也仍未得到探索。
本研究的目的是评估Cdc6蛋白、MIB-1蛋白和人乳头瘤病毒(HPV)DNA在广泛的宫颈组织中的分布情况,包括宫颈外膜和宫颈内膜黏膜的正常、潜在癌前病变和恶性病变。
我们采用间接免疫过氧化物酶法对福尔马林固定、石蜡包埋组织以及冰冻组织(包括活检和子宫切除标本)进行Cdc6和MIB-1蛋白染色,并在部分病例中采用原位杂交法检测HPV DNA。
Cdc6染色仅见于细胞核,在组织学切片的鳞状上皮细胞和腺上皮细胞中均有表达。正常宫颈鳞状黏膜标本(2/84,2.4%)或鳞状化生标本(3/59,5.1%)中很少出现Cdc6染色,在正常宫颈内膜腺体中未检测到(0/84)。大多数CIN I病例(31/48,65%)出现染色。大多数CIN II病例(25/28,89%)以及所有CIN III病例(36/36)和鳞状细胞癌病例(34/34)均出现染色。Cdc6染色的细胞比例随发育异常程度增加而升高,鳞状细胞癌中染色细胞的比例与高级别发育异常病变中的相似。大多数腺体病变病例中出现Cdc6染色,包括原位腺癌(11/14,79%)和腺癌(8/10,80%)。Cdc6免疫反应性细胞的组织学分布与HPV DNA强信号细胞的分布相似,但Cdc6蛋白和HPV DNA在单个细胞水平上并不共定位。
Cdc6表达是高级别宫颈鳞状和腺体发育异常及癌的标志物,且与HPV感染相关。HPV感染与Cdc6免疫阳性之间关联的机制基础仍有待确定,但可能代表Cdc6表达上调或Cdc6蛋白稳定。